Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,749
datasets available to search
ShareScore release 0.9.0
Dataset results
11,749 results for “patient safety”
Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
ClinicalTrials.gov study NCT02090764. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
ClinicalTrials.gov study NCT03508609. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery
ClinicalTrials.gov study NCT01660763. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
ClinicalTrials.gov study NCT00676338. IPD Sharing: Not stated. Countries: 22. Publications: 5.
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02455076. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)
ClinicalTrials.gov study NCT00524368. IPD Sharing: Not stated. Countries: 19. Publications: 1.
Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
ClinicalTrials.gov study NCT01397461. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
ClinicalTrials.gov study NCT06782373. IPD Sharing: YES. Countries: 8. Publications: 0.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
ClinicalTrials.gov study NCT00763451. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients
ClinicalTrials.gov study NCT01646671. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01471171. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).
ClinicalTrials.gov study NCT04188379. IPD Sharing: NO. Countries: 18. Publications: 1.
Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients
ClinicalTrials.gov study NCT00224003. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris
ClinicalTrials.gov study NCT01974141. IPD Sharing: Not stated. Countries: 2. Publications: 4.
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)
ClinicalTrials.gov study NCT04593641. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
ClinicalTrials.gov study NCT01423851. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients
ClinicalTrials.gov study NCT01100437. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
ClinicalTrials.gov study NCT01471574. IPD Sharing: Not stated. Countries: 13. Publications: 1.
A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT02653300. IPD Sharing: NO. Countries: 1. Publications: 4.
Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT03771378. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.